InvestorsHub Logo
Followers 4
Posts 243
Boards Moderated 0
Alias Born 01/20/2018

Re: None

Friday, 06/25/2021 9:32:22 AM

Friday, June 25, 2021 9:32:22 AM

Post# of 64359
NPHC HUGE POTENTIAL in MANY MARKETS STRONG BUY


This is really important to remember - what is in play here.

The opioid market is a $25 billion a year industry with nearly 20,000 overdose deaths.

https://www.grandviewresearch.com/industry-analysis/opioids-market

NPHC’s non-opioid pain killers are revolutionary. They will not only improve lives but save many as they are non-addictive.

MS treatment is a $15 billion a year industry and again NPHC’s products will make a massive impact here too.

A government contract for nerve agent mitigation would be game changing for the stock. Truly limitless - it would immediately perform like a vaccine stock. VXRT went from $0.03 to $25. It will happen again - to NPHC

The other synergies are countless.

This could easily be a $5- $10 acquisition candidate or far more making the purchaser $100’s of millions.

Yes - are the lack of completed filings frustrating - beyond frustrating. I think the SEC case will resolve itself and be behind them but truly it's not that critical.

What is critical is for the management to work daily on getting in front of the right people and starting their MS trials and making sure they are current before September.

I have been here for 10 years and we have a hard deadline now of September to be current ( which is only two months away) or we all basically jump off a cliff - there are no real options other than to finally deliver on many fronts.